Aram Oganesian

Title: Aram Oganesian: Innovator in Pharmaceutical Dosage Forms

Introduction

Aram Oganesian is a notable inventor based in Dublin, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid oral dosage forms. With a total of 4 patents to his name, Oganesian's work has the potential to impact treatment methodologies significantly.

Latest Patents

Oganesian's latest patents focus on the combination of decitabine and cedazuridine solid oral dosage forms. These embodiments provide solid oral dosage forms that, upon daily administration to a subject, achieve plasma levels of decitabine equivalent to a daily intravenous dose of 20 mg administered as a one-hour infusion. The inventions also include methods of treatment using these solid oral dosage forms, ensuring that the pharmacodynamic effects are comparable to those of intravenous administration.

Career Highlights

Throughout his career, Oganesian has worked with prominent companies in the pharmaceutical industry, including Otsuka Pharmaceutical Company and Taiho Pharmaceutical Company. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.

Collaborations

Oganesian has collaborated with several professionals in his field, including Nipun Davar and Jim Hwaicher Kou. These collaborations have likely enriched his work and contributed to the success of his inventions.

Conclusion

Aram Oganesian is a distinguished inventor whose work in solid oral dosage forms has the potential to transform treatment options in the pharmaceutical industry. His innovative approach and collaborations with leading companies and professionals underscore his commitment to advancing healthcare solutions.